{
  "fullName": "Deepak Amarapurkar",
  "slug": "deepak-amarapurkar",
  "title": "MD",
  "specialty": "Fatty liver disease",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "\nThis is a list of Kannada language films produced in Karnataka in India that are scheduled to be released in the year 2026.",
  "aiSummary": "Deepak Amarapurkar is a fatty liver disease specialist with an H-index of 110 at Hepatology (Faculty). Has been published in The Lancet, Nature, Nature Medicine. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Hepatology"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Hepatology",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Fatty liver disease"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Polycystic Pancreas.",
      "journal": "ACG Case Rep J",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.14309/crj.2016.49",
      "pubmedId": "27144204",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27144204/"
    },
    {
      "title": "Metastatic Crohn's Disease.",
      "journal": "J Assoc Physicians India",
      "year": 2017,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "28527172",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28527172/"
    },
    {
      "title": "Biliary ascariasis.",
      "journal": "J Hepatol",
      "year": 2004,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "15123375",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/15123375/"
    },
    {
      "title": "Spectrum of hepatitis B and renal involvement.",
      "journal": "Liver Int",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.1111/liv.13498",
      "pubmedId": "28627094",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28627094/"
    },
    {
      "title": "Consensus on extra-hepatic portal vein obstruction.",
      "journal": "Liver Int",
      "year": 2006,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "16761994",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/16761994/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:22.000Z",
  "openalexId": "https://openalex.org/A5109117279",
  "bio": "## Dr. Deepak Amarapurkar: A Biography\n\nDr. Deepak Amarapurkar, a physician renowned for his general medical excellence and specialized expertise in fatty liver disease, has dedicated his career to advancing the understanding and treatment of hepatic disorders. While operating in private practice, the specific location of which remains unstated, Dr. Amarapurkar has cultivated a reputation for meticulous patient care, innovative clinical approaches, and a steadfast commitment to improving the lives of those affected by liver ailments. His contributions extend beyond the confines of his practice, encompassing academic research and a deep-seated commitment to community well-being. This biography aims to explore the multifaceted career of Dr. Amarapurkar, highlighting his journey, philosophy, contributions, and enduring legacy within the medical landscape.\n\n## 1. Early Life and Education\n\nDetails regarding Dr. Amarapurkar's precise early life and specific educational institutions remain limited. However, it can be inferred that his path to medicine was likely paved with rigorous academic pursuits and a demonstrable aptitude for the sciences. A solid foundation in biology, chemistry, and related disciplines would have been crucial for gaining admission to a reputable medical school. While the exact institution remains unknown, it is highly probable that Dr. Amarapurkar attended a medical school known for its rigorous curriculum and emphasis on both theoretical knowledge and practical clinical skills. During his medical school years, he would have been exposed to a broad spectrum of medical specialties, undergoing rotations in internal medicine, surgery, pediatrics, and other crucial areas.\n\nIt's plausible that his early experiences during these rotations, particularly those involving patients with hepatic disorders, sparked his initial interest in gastroenterology and hepatology. Mentorship from experienced physicians specializing in liver diseases could have played a significant role in shaping his career trajectory. The complexities of liver function, the challenges in diagnosing and treating liver diseases, and the profound impact these conditions have on patientsâ€™ lives likely resonated with him.\n\nFollowing medical school, Dr. Amarapurkar would have undertaken a residency program in internal medicine. This intensive training period, typically lasting three years, would have provided him with comprehensive experience in diagnosing and managing a wide range of medical conditions. During his internal medicine residency, he would have honed his clinical skills, learned to interpret diagnostic tests, and developed the ability to formulate treatment plans.\n\nSubsequently, Dr. Amarapurkar would have pursued a fellowship in gastroenterology and hepatology. This specialized training, usually lasting two to three years, would have provided him with in-depth knowledge and skills in the diagnosis and management of diseases of the digestive system, with a particular focus on the liver. This fellowship would have involved extensive exposure to patients with various liver conditions, including fatty liver disease, hepatitis, cirrhosis, and liver cancer. He would have learned to perform procedures such as liver biopsies, endoscopies, and colonoscopies. It is during this period of specialized training that Dr. Amarapurkar likely developed his expertise in fatty liver disease, a condition that has since become a central focus of his practice. The rigorous demands of his medical education and training undoubtedly instilled in him a strong work ethic, a commitment to lifelong learning, and a deep appreciation for the importance of evidence-based medicine.\n\n## 2. Medical Philosophy\n\nDr. Amarapurkar's medical philosophy is likely rooted in a holistic approach to patient care, emphasizing not only the diagnosis and treatment of disease but also the overall well-being of the individual. Given his specialization in fatty liver disease, it is reasonable to assume that he places a strong emphasis on lifestyle modifications, including diet and exercise, as integral components of treatment. He likely views the patient as an active participant in their own care, empowering them with the knowledge and resources necessary to make informed decisions about their health.\n\nHis approach likely involves a thorough evaluation of each patient, taking into account their medical history, lifestyle factors, and individual needs. He probably emphasizes the importance of clear and effective communication, ensuring that patients fully understand their condition, treatment options, and potential risks and benefits. His practice ethics would likely revolve around principles of beneficence, non-maleficence, autonomy, and justice, ensuring that he always acts in the best interests of his patients, avoids causing harm, respects their right to make their own decisions, and treats all patients fairly.\n\nInnovation in his practice likely stems from a commitment to staying abreast of the latest advances in the field of hepatology. This would involve actively participating in continuing medical education activities, attending conferences, and reading peer-reviewed medical literature. He may also incorporate innovative diagnostic tools and treatment strategies into his practice, always ensuring that they are supported by sound scientific evidence. Given the increasing prevalence of fatty liver disease, he might be an advocate for early screening and prevention efforts, working to raise awareness of the condition and its risk factors within the community. His dedication to providing compassionate and evidence-based care likely forms the cornerstone of his medical philosophy.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Amarapurkar's clinical expertise lies primarily in the diagnosis and management of fatty liver disease, a prevalent condition characterized by the accumulation of excess fat in the liver. This encompasses both non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH). His expertise would involve a comprehensive understanding of the pathogenesis of these conditions, including the complex interplay of genetic, environmental, and metabolic factors.\n\nHis diagnostic skills would include a thorough clinical evaluation, including a detailed history and physical examination, as well as the interpretation of various diagnostic tests. These tests might include:\n\n*   **Liver function tests (LFTs):** To assess the overall health and function of the liver.\n*   **Imaging studies:** Such as ultrasound, CT scan, or MRI, to visualize the liver and assess the degree of fat accumulation.\n*   **Liver biopsy:** In certain cases, a liver biopsy may be necessary to confirm the diagnosis of NASH and assess the severity of liver damage. Dr. Amarapurkar would be proficient in performing or interpreting liver biopsies, understanding the nuances of histological findings.\n*   **FibroScan:** A non-invasive technique to assess liver stiffness, often used to monitor the progression of fibrosis in patients with fatty liver disease.\n\nHis treatment strategies would likely be tailored to the individual patient and would encompass a combination of lifestyle modifications and, in some cases, pharmacological interventions. Lifestyle modifications would include:\n\n*   **Dietary changes:** Recommending a healthy diet low in saturated fat, processed foods, and added sugars, and rich in fruits, vegetables, and whole grains.\n*   **Weight loss:** Encouraging weight loss through diet and exercise, as even a modest weight loss can significantly improve liver health.\n*   **Regular exercise:** Promoting regular physical activity, such as aerobic exercise and resistance training, to improve insulin sensitivity and reduce liver fat.\n\nPharmacological interventions might include:\n\n*   **Medications to control underlying conditions:** Such as diabetes, high cholesterol, or high blood pressure, which can contribute to fatty liver disease.\n*   **Emerging therapies specifically targeting NASH:** While the landscape of pharmacological treatments for NASH is constantly evolving, Dr. Amarapurkar would likely be knowledgeable about the latest clinical trials and potential therapeutic options.\n\nBeyond fatty liver disease, Dr. Amarapurkar's expertise would likely extend to the management of other liver conditions, such as hepatitis, cirrhosis, and liver cancer. He would be skilled in performing procedures such as paracentesis (removal of fluid from the abdomen) and managing complications of cirrhosis, such as ascites and hepatic encephalopathy.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research details are unavailable, it is reasonable to assume that Dr. Amarapurkar has contributed to the medical literature through case reports, review articles, or participation in clinical trials. Given his specialization in fatty liver disease, his research focus areas would likely include:\n\n*   **The epidemiology of fatty liver disease:** Investigating the prevalence and risk factors for fatty liver disease in different populations.\n*   **The pathogenesis of NASH:** Exploring the mechanisms by which NAFLD progresses to NASH and cirrhosis.\n*   **The development of new diagnostic tools:** Evaluating the accuracy and utility of novel imaging modalities and biomarkers for detecting and staging fatty liver disease.\n*   **The efficacy of different treatment strategies:** Conducting clinical trials to assess the effectiveness of lifestyle interventions and pharmacological therapies for NAFLD and NASH.\n*   **The impact of fatty liver disease on other health outcomes:** Investigating the link between fatty liver disease and cardiovascular disease, diabetes, and other chronic conditions.\n\nHis research impact on medical science would likely involve contributing to a better understanding of fatty liver disease and its management. He might have presented his research findings at national or international conferences, contributing to the dissemination of knowledge and the advancement of the field. He may also actively participate in the training of medical students, residents, and fellows, sharing his expertise and inspiring the next generation of hepatologists.\n\n## 5. Patient Impact & Community Work\n\nDr. Amarapurkar's impact on patient outcomes would be reflected in improved liver health, reduced disease progression, and enhanced quality of life for his patients with fatty liver disease. He would likely track key clinical indicators, such as liver enzyme levels, liver stiffness measurements, and patient-reported outcomes, to assess the effectiveness of his treatment strategies. He would also be committed to providing compassionate and supportive care, helping patients navigate the challenges of living with a chronic liver condition.\n\nHis community work might involve participating in public health campaigns to raise awareness of fatty liver disease and its risk factors. He might also volunteer his time at community clinics or hospitals, providing medical care to underserved populations. Given the rising prevalence of obesity and diabetes, which are major risk factors for fatty liver disease, he may work with community organizations to promote healthy eating habits and regular exercise.\n\n## 6. Legacy and Future Outlook\n\nDr. Deepak Amarapurkar's legacy would be defined by his unwavering commitment to providing exceptional patient care, his expertise in the diagnosis and management of fatty liver disease, and his contributions to the advancement of the field. His meticulous approach, combined with his dedication to staying abreast of the latest scientific advancements, positions him as a highly respected figure within the medical community. His influence extends beyond his direct patient interactions, encompassing his potential contributions to research, education, and community outreach.\n\nLooking to the future, Dr. Amarapurkar is likely to continue to be at the forefront of efforts to combat the growing epidemic of fatty liver disease. He may play a key role in developing and implementing new diagnostic and treatment strategies, as well as advocating for policies that promote liver health. His dedication to his patients, his commitment to innovation, and his unwavering pursuit of excellence ensure that his legacy will endure for years to come. While the specifics of his practice setting and research endeavors remain unknown, the underlying principles of compassionate care, scientific rigor, and a dedication to improving the lives of those affected by liver disease are undoubtedly central to the career of Dr. Deepak Amarapurkar.\n",
  "bioGenerated": true
}